Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
61
TWST Quote, Financials, Valuation and Earnings
Last price:
$41.20
Seasonality move
:
-11.93%
Day range:
$38.65 - $40.90
52-week range:
$23.30 - $55.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.39x
P/B ratio:
5.19x
Volume:
1.2M
Avg. volume:
1.2M
1-year change:
-6.36%
Market cap:
$2.5B
Revenue:
$376.6M
EPS (TTM):
-$1.31
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $132.3M | $203.6M | $245.1M | $313M | $376.6M | |
| Revenue Growth (YoY) | 46.87% | 53.83% | 20.41% | 27.69% | 20.32% | |
| Cost of Revenues | $80.6M | $119.3M | $155.4M | $179.6M | $185.6M | |
| Gross Profit | $51.7M | $84.2M | $89.7M | $133.3M | $191M | |
| Gross Profit Margin | 39.08% | 41.38% | 36.61% | 42.61% | 50.72% | |
| R&D Expenses | $69.1M | $120.3M | $106.9M | $90.9M | $80.3M | |
| Selling, General & Admin | $135.9M | $212.9M | $189.7M | $218.4M | $247M | |
| Other Inc / (Exp) | -$836K | $17.8M | -$10.9M | -$47.6M | -- | |
| Operating Expenses | $205M | $333.3M | $296.6M | $309.3M | $327.3M | |
| Operating Income | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Net Interest Expenses | $367K | $80K | $5K | $29K | -- | |
| EBT. Incl. Unusual Items | -$154M | -$228.3M | -$203.5M | -$208.2M | -$77M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9M | -$10.4M | $1.2M | $560K | $719K | |
| Net Income to Company | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Basic EPS (Cont. Ops) | -$3.15 | -$4.04 | -$3.60 | -$3.60 | -$1.30 | |
| Diluted EPS (Cont. Ops) | -$3.15 | -$4.04 | -$3.60 | -$3.60 | -$1.30 | |
| Weighted Average Basic Share | $48.3M | $53.9M | $56.9M | $58M | $59.8M | |
| Weighted Average Diluted Share | $48.3M | $53.9M | $56.9M | $58M | $59.8M | |
| EBITDA | -$141.3M | -$212.4M | -$177.6M | -$144.5M | -$111.4M | |
| EBIT | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Revenue (Reported) | $132.3M | $203.6M | $245.1M | $313M | $376.6M | |
| Operating Income (Reported) | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Operating Income (Adjusted) | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $38M | $57.3M | $66.9M | $84.7M | $99M | |
| Revenue Growth (YoY) | 17.02% | 51% | 16.82% | 26.54% | 16.88% | |
| Cost of Revenues | $22.5M | $31.6M | $42.4M | $46.5M | $48.2M | |
| Gross Profit | $15.5M | $25.7M | $24.5M | $38.2M | $50.8M | |
| Gross Profit Margin | 40.72% | 44.88% | 36.63% | 45.13% | 51.35% | |
| R&D Expenses | $19.4M | $29.6M | $23.7M | $21.1M | $17M | |
| Selling, General & Admin | $38.2M | $54.2M | $47.4M | $53.1M | $63.8M | |
| Other Inc / (Exp) | $1.4M | $5.3M | -$3.7M | -$2.3M | -- | |
| Operating Expenses | $57.7M | $83.8M | $71.1M | $74.3M | $80.8M | |
| Operating Income | -$42.2M | -$58M | -$46.6M | -$36M | -$29.9M | |
| Net Interest Expenses | $83K | $26K | $1K | $28K | -- | |
| EBT. Incl. Unusual Items | -$40.9M | -$50.8M | -$46.5M | -$34.8M | -$26.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $340K | $292K | -$221K | -$96K | $256K | |
| Net Income to Company | -$41.2M | -$51.1M | -$46.2M | -$34.7M | -$27.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$41.2M | -$51.1M | -$46.2M | -$34.7M | -$27.1M | |
| Basic EPS (Cont. Ops) | -$0.84 | -$0.91 | -$0.81 | -$0.59 | -$0.45 | |
| Diluted EPS (Cont. Ops) | -$0.84 | -$0.91 | -$0.81 | -$0.59 | -$0.45 | |
| Weighted Average Basic Share | $49.4M | $56.3M | $57.3M | $58.6M | $60.4M | |
| Weighted Average Diluted Share | $49.4M | $56.3M | $57.3M | $58.6M | $60.4M | |
| EBITDA | -$38.6M | -$35.6M | -$38.1M | -$29.4M | -$23.9M | |
| EBIT | -$42.2M | -$58M | -$46.6M | -$36M | -$29.9M | |
| Revenue (Reported) | $38M | $57.3M | $66.9M | $84.7M | $99M | |
| Operating Income (Reported) | -$42.2M | -$58M | -$46.6M | -$36M | -$29.9M | |
| Operating Income (Adjusted) | -$42.2M | -$58M | -$46.6M | -$36M | -$29.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $132.3M | $203.6M | $245.1M | $313M | $376.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $80.6M | $119.3M | $155.4M | $179.6M | $185.6M | |
| Gross Profit | $51.7M | $84.2M | $89.7M | $133.3M | $191M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $69.1M | $120.3M | $106.9M | $90.9M | $80.3M | |
| Selling, General & Admin | $135.9M | $212.9M | $189.7M | $218.4M | $247M | |
| Other Inc / (Exp) | -$836K | $17.8M | -$10.9M | -$47.6M | -- | |
| Operating Expenses | $205M | $333.3M | $296.6M | $309.3M | $327.3M | |
| Operating Income | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Net Interest Expenses | $366K | $81K | $5K | $28K | $167K | |
| EBT. Incl. Unusual Items | -$154M | -$228.3M | -$203.5M | -$208.2M | -$77M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9M | -$10.4M | $1.2M | $560K | $719K | |
| Net Income to Company | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Basic EPS (Cont. Ops) | -$3.15 | -$4.03 | -$3.60 | -$3.60 | -$1.30 | |
| Diluted EPS (Cont. Ops) | -$3.15 | -$4.03 | -$3.60 | -$3.60 | -$1.31 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$141.2M | -$212.4M | -$176.5M | -$144.5M | -$111.7M | |
| EBIT | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Revenue (Reported) | $132.3M | $203.6M | $245.1M | $313M | $376.6M | |
| Operating Income (Reported) | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Operating Income (Adjusted) | -$153.3M | -$249M | -$206.9M | -$175.9M | -$136.3M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $203.6M | $245.1M | $313M | $376.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $119.3M | $155.4M | $179.6M | $185.6M | -- | |
| Gross Profit | $84.2M | $89.7M | $133.3M | $191M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $120.3M | $106.9M | $90.9M | $80.3M | -- | |
| Selling, General & Admin | $212.9M | $189.7M | $218.4M | $247M | -- | |
| Other Inc / (Exp) | $17.8M | -$10.9M | -$47.6M | -$320K | -- | |
| Operating Expenses | $333.3M | $296.6M | $309.3M | $327.3M | -- | |
| Operating Income | -$249M | -$206.9M | -$175.9M | -$136.3M | -- | |
| Net Interest Expenses | $81K | $5K | $28K | $167K | -- | |
| EBT. Incl. Unusual Items | -$228.3M | -$203.5M | -$208.2M | -$77M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$10.4M | $1.2M | $560K | $719K | -- | |
| Net Income to Company | -$217.9M | -$204.6M | -$208.7M | -$77.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$217.9M | -$204.6M | -$208.7M | -$77.7M | -- | |
| Basic EPS (Cont. Ops) | -$4.03 | -$3.60 | -$3.60 | -$1.30 | -- | |
| Diluted EPS (Cont. Ops) | -$4.03 | -$3.60 | -$3.60 | -$1.31 | -- | |
| Weighted Average Basic Share | $215.9M | $227.5M | $232M | $239.2M | -- | |
| Weighted Average Diluted Share | $215.9M | $227.5M | $232M | $240.4M | -- | |
| EBITDA | -$212.4M | -$176.5M | -$144.5M | -$111.7M | -- | |
| EBIT | -$249M | -$206.9M | -$175.9M | -$136.3M | -- | |
| Revenue (Reported) | $203.6M | $245.1M | $313M | $376.6M | -- | |
| Operating Income (Reported) | -$249M | -$206.9M | -$175.9M | -$136.3M | -- | |
| Operating Income (Adjusted) | -$249M | -$206.9M | -$175.9M | -$136.3M | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $477.9M | $505M | $336.4M | $276.4M | $232.4M | |
| Short Term Investments | $12M | $126.3M | $49.9M | $50.1M | -- | |
| Accounts Receivable, Net | $26.2M | $35.5M | $44.1M | $34.9M | $57M | |
| Inventory | $31.8M | $39.3M | $32.1M | $24.1M | $28.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $8.3M | $11.9M | $11.7M | $11.4M | -- | |
| Total Current Assets | $546.5M | $596.5M | $424.3M | $346.8M | $333M | |
| Property Plant And Equipment | $105.7M | $214.4M | $203.4M | $161.3M | $151.7M | |
| Long-Term Investments | $1.5M | $1.6M | $2.8M | $4.3M | $58.5M | |
| Goodwill | $22.4M | $85.8M | $85.8M | $85.8M | -- | |
| Other Intangibles | $18.3M | $59.7M | $54.5M | $14.5M | -- | |
| Other Long-Term Assets | $6.2M | $5M | $8.5M | $5.9M | -- | |
| Total Assets | $702.1M | $961.4M | $776.4M | $614.3M | $641.9M | |
| Accounts Payable | $14.9M | $20.1M | $14.1M | $1.6M | $11.1M | |
| Accrued Expenses | $6.4M | $10.2M | $10.8M | $15.1M | -- | |
| Current Portion Of Long-Term Debt | $1.6M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8.2M | $13.6M | $14.9M | $14.8M | -- | |
| Other Current Liabilities | $6.1M | $12.6M | $430K | $961K | -- | |
| Total Current Liabilities | $63.1M | $90.7M | $73.3M | $71M | $91.4M | |
| Long-Term Debt | $53.2M | $81.3M | $79.2M | $70.2M | $61.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $121.3M | $172M | $153M | $141.6M | $168.9M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $546K | -$1.8M | -$756K | -$522K | -- | |
| Common Equity | $580.8M | $789.4M | $623.4M | $472.7M | $473M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $580.8M | $789.4M | $623.4M | $472.7M | $473M | |
| Total Liabilities and Equity | $702.1M | $961.4M | $776.4M | $614.3M | $641.9M | |
| Cash and Short Terms | $477.9M | $505M | $336.4M | $276.4M | $232.4M | |
| Total Debt | $54.7M | $81.3M | $79.2M | $70.2M | $61.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $477.9M | $505M | $336.4M | $276.4M | $232.4M | |
| Short Term Investments | $12M | $126.3M | $49.9M | $50.1M | -- | |
| Accounts Receivable, Net | $26.2M | $35.5M | $44.1M | $34.9M | $57M | |
| Inventory | $31.8M | $39.3M | $32.1M | $24.1M | $28.3M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $8.3M | $11.9M | $11.7M | $11.4M | -- | |
| Total Current Assets | $546.5M | $596.5M | $424.3M | $346.8M | $333M | |
| Property Plant And Equipment | $105.7M | $214.4M | $203.4M | $161.3M | $151.7M | |
| Long-Term Investments | $1.5M | $1.6M | $2.8M | $4.3M | $58.5M | |
| Goodwill | $22.4M | $85.8M | $85.8M | $85.8M | -- | |
| Other Intangibles | $18.3M | $59.7M | $54.5M | $14.5M | -- | |
| Other Long-Term Assets | $6.2M | $5M | $8.5M | $5.9M | -- | |
| Total Assets | $702.1M | $961.4M | $776.4M | $614.3M | $641.9M | |
| Accounts Payable | $14.9M | $20.1M | $14.1M | $1.6M | $11.1M | |
| Accrued Expenses | $6.4M | $10.2M | $10.8M | $15.1M | -- | |
| Current Portion Of Long-Term Debt | $1.6M | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $8.2M | $13.6M | $14.9M | $14.8M | -- | |
| Other Current Liabilities | $6.1M | $12.6M | $430K | $961K | -- | |
| Total Current Liabilities | $63.1M | $90.7M | $73.3M | $71M | $91.4M | |
| Long-Term Debt | $53.2M | $81.3M | $79.2M | $70.2M | $61.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $121.3M | $172M | $153M | $141.6M | $168.9M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $546K | -$1.8M | -$756K | -$522K | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $580.8M | $789.4M | $623.4M | $472.7M | $473M | |
| Total Liabilities and Equity | $702.1M | $961.4M | $776.4M | $614.3M | $641.9M | |
| Cash and Short Terms | $477.9M | $505M | $336.4M | $276.4M | $232.4M | |
| Total Debt | $54.7M | $81.3M | $79.2M | $70.2M | $61.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Depreciation & Amoritzation | $12M | $36.6M | $29.3M | $31.4M | $24.9M | |
| Stock-Based Compensation | $37M | $79.7M | $30.3M | $50.9M | $64.5M | |
| Change in Accounts Receivable | -$2.2M | -$9.6M | -$4.3M | $8.4M | -$22.4M | |
| Change in Inventories | -$19.5M | -$7.5M | $7.2M | $8M | -$4.2M | |
| Cash From Operations | -$112.2M | -$124.4M | -$142.5M | -$64.1M | -$47.6M | |
| Capital Expenditures | $27.1M | $101.9M | $27.8M | $5.1M | $28M | |
| Cash Acquisitions | $483K | $8.2M | -- | -- | -- | |
| Cash From Investing | $156.2M | -$232.9M | $50.6M | -$3.1M | -$24.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.3M | -$1.6M | -- | -- | -- | |
| Repurchase of Common Stock | $10.8M | $7.8M | $4.4M | $4M | $16K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $329.2M | $270.5M | $911K | $6.9M | $28.5M | |
| Beginning Cash (CF) | $465.8M | $378.7M | $286.5M | $226.3M | $183M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $373.1M | -$87.1M | -$91M | -$60.1M | -$43.7M | |
| Ending Cash (CF) | $839M | $291.3M | $195.5M | $166.3M | $139.5M | |
| Levered Free Cash Flow | -$139.3M | -$226.2M | -$170.3M | -$69.2M | -$75.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$41.2M | -$51.1M | -$46.2M | -$34.7M | -$27.1M | |
| Depreciation & Amoritzation | $3.6M | $22.5M | $7.5M | $6.7M | $6M | |
| Stock-Based Compensation | $9.2M | $19M | $11.7M | $12.3M | $16.1M | |
| Change in Accounts Receivable | -$290K | $662K | -$1.8M | -$3M | -$7.2M | |
| Change in Inventories | -$10.6M | $3.7M | $4.3M | $4.4M | -$2.4M | |
| Cash From Operations | -$34.8M | -$1.3M | -$20.7M | -$15.3M | -$11.8M | |
| Capital Expenditures | $8.1M | $16.5M | $2.4M | $2M | $12.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $23.9M | $2.8M | -$2.2M | -$1.3M | -$12.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$833K | -- | -- | -- | -- | |
| Repurchase of Common Stock | $2.6M | $1.6M | $1.1M | $8K | $2K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.6M | $1.2M | $442K | $3.6M | $5.6M | |
| Beginning Cash (CF) | $465.8M | $378.7M | $286.5M | $226.3M | $183M | |
| Foreign Exchange Rate Adjustment | -$133K | -$318K | -$48K | $73K | $163K | |
| Additions / Reductions | -$9.5M | $2.4M | -$22.6M | -$12.9M | -$18.5M | |
| Ending Cash (CF) | $456.2M | $380.8M | $263.9M | $213.5M | $164.7M | |
| Levered Free Cash Flow | -$42.9M | -$17.7M | -$23.1M | -$17.3M | -$24.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$152.1M | -$217.9M | -$204.6M | -$208.7M | -$77.7M | |
| Depreciation & Amoritzation | $12M | $36.6M | $29.3M | $31.4M | $24.9M | |
| Stock-Based Compensation | $37M | $79.7M | $30.3M | $50.9M | $64.5M | |
| Change in Accounts Receivable | -$2.2M | -$9.6M | -$4.3M | $8.4M | -$22.4M | |
| Change in Inventories | -$19.5M | -$7.5M | $7.2M | $8M | -$4.2M | |
| Cash From Operations | -$112.2M | -$124.4M | -$142.5M | -$64.1M | -$47.6M | |
| Capital Expenditures | $27.1M | $101.9M | $27.8M | $5.1M | $28M | |
| Cash Acquisitions | $483K | $8.2M | -- | -- | -- | |
| Cash From Investing | $156.2M | -$232.9M | $50.6M | -$3.1M | -$24.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.3M | -$1.6M | -- | -- | -- | |
| Repurchase of Common Stock | $10.8M | $7.8M | $4.4M | $4M | $16K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $329.2M | $270.5M | $911K | $6.9M | $28.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $373.1M | -$87.1M | -$91M | -$60.1M | -$43.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$139.3M | -$226.2M | -$170.3M | -$69.2M | -$75.6M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$217.9M | -$204.6M | -$208.7M | -$77.7M | -- | |
| Depreciation & Amoritzation | $36.6M | $29.3M | $31.4M | $24.9M | -- | |
| Stock-Based Compensation | $79.7M | $30.3M | $50.9M | $64.5M | -- | |
| Change in Accounts Receivable | -$9.6M | -$4.3M | $8.4M | -$22.4M | -- | |
| Change in Inventories | -$7.5M | $7.2M | $8M | -$4.2M | -- | |
| Cash From Operations | -$124.4M | -$142.5M | -$64.1M | -$47.6M | -- | |
| Capital Expenditures | $101.9M | $27.8M | $5.1M | $28M | -- | |
| Cash Acquisitions | $8.2M | -- | -- | -- | -- | |
| Cash From Investing | -$232.9M | $50.6M | -$3.1M | -$24.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.6M | -- | -- | -- | -- | |
| Repurchase of Common Stock | $7.8M | $4.4M | $4M | $16K | -- | |
| Other Financing Activities | -- | -- | -- | $15M | -- | |
| Cash From Financing | $270.5M | $911K | $6.9M | $28.5M | -- | |
| Beginning Cash (CF) | $1.4B | $1.2B | $975.1M | $816.3M | -- | |
| Foreign Exchange Rate Adjustment | -$319K | -$27K | $126K | $143K | -- | |
| Additions / Reductions | -$87.1M | -$91M | -$60.1M | -$43.7M | -- | |
| Ending Cash (CF) | $1.3B | $1.1B | $915.1M | $772.7M | -- | |
| Levered Free Cash Flow | -$226.2M | -$170.3M | -$69.2M | -$75.6M | -- | |
Get TWST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TWST
Sector
P/E ratio
--
23.89x
PEG ratio
-3.49x
-0.01x
P/B ratio
5.19x
1.82x
Price / LTM sales
6.39x
1.60x
Growth Metrics
TWST
Sector
Revenue growth
16.88%
4.35%
Earnings growth
24.11%
9.95%
Revenue (5-year growth)
33.11%
6.41%
Earnings forecast
-$0.52
-$0.18
Profitability
TWST
Sector
Profitability FY 2025
$191M
$3.4M
Return on invested capital
-14.27%
-32.69%
Return on assets
-12.51%
-29%
Return on equity
-16.74%
-38.43%
Earnings Date
Last Earnings Date
Nov
14
Next Earnings Date
Feb
2
Estimated Next Earnings Date
Feb
13
Balance Sheet
TWST
Sector
Total cash
$232.4M
$25.7M
Short term investments
$50.1M
$25.5M
Total assets
$641.9M
$75.6M
Long term debt
$61.8M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
53
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
80
BNR alert for Jan 15
Burning Rock Biotech Ltd. [BNR] is up 19.14% over the past day.
Sell
37
TCOM alert for Jan 15
Trip.com Group Ltd. [TCOM] is down 2.61% over the past day.
Sell
39
DAVE alert for Jan 15
Dave, Inc. [DAVE] is up 2.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
